Concepedia

Anastasia Shneyderman

AS

Statistics

Publications

8

Citations

512

H-Index

8

Active since

2021

Affiliations

Hong Kong Science and Technology Parks Corporation(Current)

University of Chicago

Palo Alto University

Harvard University

University of Copenhagen

Anastasia Shneyderman is an author at Hong Kong Science and Technology Parks Corporation specializing in molecular oncology, drug discovery, and cancer biology.

ORCID

Publications per year

2021–2024

8

Publications

8

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 326 citations · Full text

, , +8

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Frank W. Pun, Bonnie Hei Man Liu, Xi Long et al. · Frontiers in Aging Neuroscience · 2022 · 99 citations · Full text

, , +17

High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders

Garik V. Mkrtchyan, Alexander Veviorskiy, Evgeny Izumchenko et al. · Cell Death and Disease · 2022 · 20 citations · Full text

, , +17

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform

Andrea Olsen, Zachary Harpaz, Christopher X. Ren et al. · Aging · 2023 · 18 citations · Full text

, , +17

Precious3GPT: Multimodal Multi-Species Multi-Omics Multi-Tissue Transformer for Aging Research and Drug Discovery

Fedor Galkin, Stefan Pushkov, Denis Sidorenko et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 16 citations · Full text

, , +13

1–5 of 8